Primary Site >> Liver Cancer

Gene >> PROK2

Journal: J Clin Oncol. 2002 Mar 15;20(6):1668-76.
Title: Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
Author: Seymour, Leonard W|Ferry, David R|Anderson, David|Hesslewood, Stuart|Julyan, Peter J|Poyner, Richard|Doran, Jayne|Young, Annie M|Burtles, Sally|Kerr, David J
PMID: 11896118
Journal: World J Gastroenterol. 2008 Feb 28;14(8):1182-91.
Title: Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.
Author: Monnier, Justin|Piquet-Pellorce, Claire|Feige, Jean-Jacques|Musso, Orlando|Clement, Bruno|Turlin, Bruno|Theret, Nathalie|Samson, Michel
PMID: 18300343
Journal: J Control Release. 2015 Jul 10;209:288-307.
Title: New trends in guided nanotherapies for digestive cancers: A systematic review.
Author: Fernandes, Elisabete|Ferreira, Jose Alexandre|Andreia, Peixoto|Luis, Lima|Barroso, Sergio|Sarmento, Bruno|Santos, Lucio Lara
PMID: 25957905
Journal: Turk J Med Sci. 2018 Feb 23;48(1):52-61.
Title: Relationship between PK2 and number of Kupffer cells during the progression of liver fibrosis in patients with HBV
Author: Liu, Xiao-Qin|Wei, Rong-Rong|Wang, Cheng-Cheng|Chen, Li-Yu|Liu, Cong|Liu, Kai
PMID: 29479955